ADVERTISEMENT

The Path To Commercialize CAR-T Cell Products

Different cancer treatments exist, but they each have variable efficacies and non-negligible side effects

Many innovative approaches are under development in research labs or are being tested in phase I/II trials. Among such treatments are genetically-engineered CAR T cells that bypass the natural function of patients’ T cells to efficiently target and kill tumors. Two CAR T cell products were recently approved by the FDA, and their administration is limited to certified centers in the US.

ADVERTISEMENT

Dedicated manufacturing setups are necessary to produce such cells, rendering them more expensive than conventional treatments and less accessible to patients. CAR-T cells will possibly herald the first commercial success of industry-manufactured cellular therapies, an activity that has historically been developed and supported by academia in an organizational context different than the industrial pharma framework.

In this review, we discuss the hurdles on the path to commercialization of CAR T cells. The complexity of the supply chain, from primary cell collection to administration of a personalized medicinal product, is hardly amenable to the conventional central manufacturing processes used for conventional drug batch production. This warrants exploring whether alternative models of manufacturing (centralized versus point-of-care) is compatible with modern regulations, patient safety, and cost containment.

In part ‚ÄĒ but not only ‚ÄĒ because current organizations for manufacturing necessitate cross-border shipping of the starting material and of the medicinal product ready to be administered, a harmonization of regulations is needed to speed up access for patients in many countries. To paraphrase one of the first patients treated with CAR-T cells in the US, a treatment that is not accessible to many is not a cure at all.

CAR T cells also carry significant risks of toxicities. For broad applicability, engineering safety mechanisms into the gene constructs of CAR T cells is required.

ADVERTISEMENT

We also discuss avenues to increase the likelihood of commercial success of CAR T cells:

  • Point-of-care technologies can reduce the complexity of the supply chain by collecting cells from a patient, manufacturing CAR T cells, and infusing to the same patient at the same site;
  • Adopting an off-the-shelf approach for readily-available stocks/batches of CAR T cells accessible to large numbers of patients, as opposed to the current model of patient-specific CAR T cells; and
  • Building on the success of CAR T cells in leukemias and lymphomas to target other more prevalent tumors, such as solid tumors, is a most desirable goal, however, this implies a better knowledge of tumor antigens, trafficking of immune cells in the vicinity of tumor cells, and the immunosuppressive properties of the tumor microenvironment.
Figure: Major pharmaceutical industry players currently contributing to developments in the CAR-T cell field (Republished with permission from Elsevier)

These findings are described in the article entitled, From clinical proof-of-concept to commercialization of CAR T cells, recently published in the journal Drug Discovery Today. This work was conducted by Boris Calmels, Bechara Mfarrej, and Christian Chabannon from Aix Marseille University and the Institut Paoli-Calmettes.

Comments

READ THIS NEXT

Nucleic Acid Monomer

Nucleic acids (a.k.a DNA and RNA) are composed out of monomer units called nucleotides.¬†Nucleotides are the basic building blocks of […]

Examining Parasitoid Effects On Aphid Populations In Québec

Insect pest populations are known to be regulated, at least in part, by naturally-occurring natural enemies such as pathogens, predators, […]

Recent Giant Python Attacks Will Increase As Deforestation Increases

The reticulated python is one of the strongest and longest snakes in the world. The snake coils around its prey […]

Taming Elusive Molecules For Energy Conversion, Pollutant Removal, And Generation Of Valuable Resources

Every day we are surrounded by chemical processes that improve our quality of life, while most of us are not […]

Life Cycle Of A Butterfly: Stages Of Life

The life cycle of a butterfly includes a process called metamorphosis where each butterfly goes through 4 stages from an […]

Towards Cheap, Miniaturized, Robust Sensors For Explosives 

The compound 2,4,6-Trinitrotoluene (TNT) is an explosive material widely used for military, industrial, and mining applications. Its reduction products are […]

Investigating How The Indian Monsoon Impacts Climate On The Tibetan Plateau

The Tibetan Plateau (TP), known as the ‚ÄúThird Pole‚ÄĚ and the ‚Äúworld water tower‚ÄĚ, hosts the largest ice mass outside […]

Science Trends is a popular source of science news and education around the world. We cover everything from solar power cell technology to climate change to cancer research. We help hundreds of thousands of people every month learn about the world we live in and the latest scientific breakthroughs. Want to know more?